Researchers - Kenneth Rainin Foundation

Researchers

Supporting new and seasoned investigators alike and embracing untested ideas gives us the best chance of discovering breakthroughs in IBD research. Get to know our Health Program grantees.

Andrei Ivanov, Professor, Cleveland Clinic

Andrei Ivanov, PhD

Professor, Cleveland Clinic, Former Grantee

The Ivanov lab studies mechanisms that regulate cell-cell adhesions and epithelial barriers under normal homeostatic conditions and mechanisms controlling disruption and recovery of epithelial barriers during inflammation and infection.
Ruaidhrí Jackson, Assistant Professor, Harvard Medical School

Ruaidhrí Jackson, PhD

Assistant Professor, Harvard Medical School, Former Grantee

The Jackson lab explores unknown molecules, sensory pathways and cellular connections that underpin inflammation. They aim to uncover not only how tissue-wide homeostasis is achieved but also how its breakdown can be averted to prevent disease.
Headshot of Miguel Jimenez

Miguel Jimenez

Assistant Professor, Boston University, Current Grantee

Dr. Jimenez’s group develops material, genetic and fabrication approaches to enable integration of living microorganisms into products that can be used for human health, agriculture, the environment and art.
Headshot of Marco Jost

Marco Jost, PhD

Assistant Professor, Harvard College, Current Grantee

The Jost lab studies the chemical signaling between microbes in the microbiome and human cells, with the goal of creating a molecular-level understanding of how the microbiome shapes human biology in health and disease.
Nobuhiko Kamada, Professor, University of Michigan

Nobuhiko Kamada, PhD

Professor, University of Michigan, Former Grantee

Dr. Kamada’s lab investigates how gut microbiota and host immunity interact in gastrointestinal health and disease. Their focus is on the mechanism by which certain pathogenic members of commensal bacteria promote chronic intestinal inflammation that leads to Inflammatory Bowel Disease.
Headshot of Michael Kattah

Michael Kattah, MD, PhD

Assistant Professor; University of California, San Francisco; Current Grantee

The Kattah Lab aims to understand how intestinal epithelial cells contribute to disease. The ultimate goal is to develop patient-tailored treatment strategies that maximize efficacy and minimize toxicity for individual patients.